Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Neri, A

Class:IdPerson:2032860
_displayNameNeri, A
_timestamp2012-01-08 03:48:37
created[InstanceEdit:2032861] Rothfels, K, 2012-01-08
firstnameAntonino
initialA
surnameNeri
(author)[LiteratureReference:2032925] Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations
[LiteratureReference:2064378] Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)
[LiteratureReference:9725240] Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
[LiteratureReference:9726084] Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
[LiteratureReference:9846040] Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
[LiteratureReference:9851385] Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents
[Change default viewing format]
No pathways have been reviewed or authored by Neri, A (2032860)